NAGA 抗体 (AA 43-329) (Fluoro647)
Our Local Distributor
北京 101111
Quick Overview for NAGA 抗体 (AA 43-329) (Fluoro647) (ABIN8012972)
抗原
See all NAGA 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 43-329
-
原理
- Anti-NAGA Antibody Fluoro647 Conjugated
-
交叉反应 (详细)
- No cross-reactivity with other proteins
-
预测反应
- Human NAGAshares 86.7%,85.4% amino acid (aa) sequence identity with mouse,rat NAGA,respectively.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E.coli-derived human NAGA recombinant protein (Position: D43-R329). Human NAGAshares 86.7% and 85.4% amino acid (aa) sequence identity with mouse and rat NAGA, respectively.
-
亚型
- IgG
-
-
-
-
应用备注
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
有效期
- 12 months
-
-
- NAGA (N-Acetylgalactosaminidase, alpha (NAGA))
-
别名
- NAGA
-
背景
-
Background: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
Gene Full Name: alpha-N-acetylgalactosaminidase
-
基因ID
- 4668
-
UniProt
- P17050
抗原
-